SEC Form 4 · accession 0001728564-18-000006
abrdn Life Sciences Investors · HQL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas M Kent
Director
Period of report
Jan 25, 2018
Accepted (ET)
Jan 29, 2018 · 10:07 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884121
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Shares of Beneficial Interest | Jan 25, 2018 | P | 1,300 | $21.0369 | A | 1,300 | D |
Table II — derivative securities
No Table II lines on this filing.